Clinical Trials Browser

Lymphoma, Large B-Cell, Diffuse

Prostatic Neoplasms

Prostatic Neoplasms, Castration-Resistant

Prostatic Neoplasms

Leukemia, Hairy Cell, Lymphoma, Non-Hodgkin, Neoplasms, Recurrence, Lymphoma, Large B-Cell, Diffuse

Metastatic Castration-resistant Prostate Neoplasms

Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Neoplasms

Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, Mantle-Cell

Prostatic Neoplasms

Adrenal Insufficiency, Myasthenia Gravis

Prostate Cancer Metastatic

Lymphoma, Large B-Cell, Diffuse

Prostatic Neoplasms

Prostatic Neoplasms, Castration-Resistant

Biliary Tract Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

Lymphoma, Follicular

Prostatic Neoplasms

Prostatic Neoplasms

Metastatic Castration-Resistant Prostate Cancer

Neoplasm Metastasis, Prostatic Neoplasms

Lymphoma, B-Cell

Prostatic Neoplasms

Lymphoma, Follicular

Lymphoma, T-Cell, Peripheral

Lymphoma, T-Cell, Peripheral

Prostatic Neoplasms

Lymphoma, Large B-Cell, Diffuse

Advanced Solid Tumor

Lymphoma, B-Cell

Clinical Trials

MK-2140-010

MK-5684-004

KLK2-PASenger

A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma

A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer

EPCORE™FL-2

Soundtrack-E

MK-2400-001

OCTAGON

OMAHA-003

MK-2140-011

A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

MK-5684-01A

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types

OLYMPIA-1

EvoPAR-PR02

A Study to Evaluate the Safety and Drug Levels of ASP5541 in Chinese Participants With Prostate Cancer

KEYNOTE-365

A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma

A Study of HRS-5041 Tablets Combined With Antitumor Therapy in Subjects With Advanced Prostate Cancer

A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)

CRESCENDO

Tucidinostat in Combination With CHOP in Newly Diagnosed Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype

A Study for the Treatment of Metastatic Prostate Cancer With HRS-1167 Tablets Combined With Abiraterone Acetate Tablets and Prednisone

A Study of HDM2005 in Combination With Standard of Care in Patients With Diffuse Large B-Cell Lymphoma

A Study of CS5001 in Patients With Advanced Solid Tumors and Lymphomas

Phase Ib Study of Rocbrutinib in Combination With R-CHOP in Patients With Newly Diagnosed B-cell Non-Hodgkin Lymphoma